{
    "Variants Include": [
        {
            "Gene": "PINK1",
            "variants": [
                {
                    "HGVS": "NM_032409.3:c.926G>A",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "926"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "309"
                    },
                    "Description in input context": "G309D"
                },
                {
                    "HGVS": "NM_032409.3:c.1040T>C",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "T",
                        "alt": "C",
                        "position": "1040"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "P",
                        "position": "347"
                    },
                    "Description in input context": "L347P"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Recessive Parkinsonism",
        "MONDO": "MONDO:0011613"
    },
    "Experiment Method": [
        {
            "Assay Method": "In Vitro Kinase Assays",
            "Material used": {
                "Material Source": "Bacterial Expression System",
                "Material Name": "Escherichia coli BL21 (DE3)",
                "Description": "PINK1 fusion proteins were expressed in Escherichia coli BL21 (DE3)[cite: 54]. Cells were grown at 37°C until the OD600 reached 0.7–0.8 and then were induced with isopropyl β-D-thiogalactopyranoside to a final concentration of 0.2 mM at 37°C for 3 h[cite: 55]. Cells were harvested and lysed by sonication on ice in lysis buffer containing 50 mM Tris-HCl (pH 7.4), 200 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1%, Triton X-100, and protease inhibitors[cite: 56]. After centrifugation for 20 min at 12,000 g, the supernatant was incubated with Glutathione Sepharose 4B beads (Amersham Pharmacia Biosciences) overnight at 4°C[cite: 57]. The beads were washed extensively with lysis buffer and prepared for SDS/PAGE by addition of 2× SDS sample buffer and then heating at 95°C for 5 min[cite: 58]."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "G309D had somewhat decreased activity (60.5% of wild type; P = 0.01)[cite: 134]."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "L347P had drastically decreased activity (<10% of wild type)[cite: 134]. Recombinant L347P GST-PINK1 fusions were unstable[cite: 135]."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Differences in autophosphorylation activity between different recombinant proteins (n = 3) were analyzed by using ANOVA with Fisher’s PLSD post hoc test[cite: 64, 112, 113]."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 (lane 1) is shown for comparison with artificial kinase mutants[cite: 111]. Autophosphorylation activity of wild-type PINK1 GST-fusion proteins[cite: 107]."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Artificial kinase-dead mutant (K219A, D362A, D384A, triple kinase-dead mutant)[cite: 111]."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA with Fisher’s PLSD post hoc test [cite: 64, 113]"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Immunoblotting",
            "Material used": {
                "Material Source": "Mammalian Cells",
                "Material Name": "COS7 or M17 (human neuroblastoma) cells [cite: 51]",
                "Description": "COS7 or M17 (human neuroblastoma) cells were grown in Opti-MEM supplemented with 10% (vol/vol) FBS (Invitrogen) and were transiently transfected by using FuGENE (Roche Applied Science, Indianapolis)[cite: 51, 52]. Proteins resolved on SDS/PAGE were blotted as described in refs. 11 and 23[cite: 65]. Antibodies used were monoclonal anti-GFP (clones 7.1 and 13.1, Roche Applied Science), anti-myc (clone 9E10, Roche Applied Science), and anti-β-actin (clone AC15, Sigma)[cite: 66]. Blots were imaged by using a Storm phosphorimager, and the relative intensity of immunoreactive bands was measured by using IMAGEQUANT 5.2 and normalized to β-actin[cite: 67]."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "No effect was noted for G309D constructs[cite: 167]. G309D PINK1, however, appeared to be normally localized[cite: 174]."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "The amount of transfected PINK1 was drastically decreased by using the L347P mutant[cite: 164]. Quantification showed that there was a very dramatic decrease in the amount of L347P protein[cite: 165]. The level of L347P protein was significantly (P < 0.01) less than that of wild type or other constructs when measuring either preprotein or mature protein[cite: 166]. L347P PINK1 gave much lower levels of immunostaining, especially for the C-terminal constructs[cite: 173]."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "All data represent the means ± SEM from at least triplicate determinations[cite: 68]. We quantified both protein and mRNA expression for all constructs from n = 3 experiments[cite: 182]."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild type (lanes 2 and 3) control[cite: 180]."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Untransfected cells[cite: 90, 179]. Kinase-dead construct (lanes 4 and 5)[cite: 180]."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA [cite: 166]"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Quantitative RT-PCR",
            "Material used": {
                "Material Source": "Mammalian Cells",
                "Material Name": "COS-7 cells",
                "Description": "Total RNA was isolated from cells 48 h after transfection by using TRIzol (Invitrogen)[cite: 74]. The isolated RNA was treated with a DNase I (Invitrogen), and 1-µg quantities of total RNA were reverse transcribed separately with SuperScript III reverse transcriptase (Invitrogen) by using oligo(dT) primers[cite: 75]. cDNA templates were diluted 10-fold before use in RT-PCR[cite: 76]. Primers for PINK1 were 5'-AGACGCTTGCAGGGCTTTC-3' (forward) and 5'-GGCAATGTAGGCATGGTGG-3' (reverse)[cite: 76]. Primers for β-actin were 5'-AGAAGGATTCCTATGTGGGCG-3' (forward) and 5'-CATGTCGTCCCAGTTGGT-GAC-3' (reverse)[cite: 77]. Real-time quantitative PCR was performed and analyzed by using the Applied Biosystems 7900 system as described in ref. 25[cite: 78]."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "No effect was noted for G309D constructs[cite: 167]. There were no statistically significant differences between mRNA levels (P = 0.23 by ANOVA; n = 3)[cite: 166]."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "mRNA levels were not decreased for L347P mutant[cite: 165]. There were no statistically significant differences between mRNA levels (P = 0.23 by ANOVA; n = 3)[cite: 166]."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "We quantified both protein and mRNA expression for all constructs from n = 3 experiments[cite: 182]."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild type control[cite: 180]."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Untransfected cells[cite: 179]."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA [cite: 166]"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Pulse–Chase Labeling",
            "Material used": {
                "Material Source": "Mammalian Cells",
                "Material Name": "COS-7 cells [cite: 69]",
                "Description": "Cos-7 cells were transiently transfected with GFP-tagged PINK1[cite: 69]. Forty-eight hours after transfection, cells were starved in methionine/cysteine-free DMEM (Gibco-BRL) plus 1% L-glutamine for 1 h[cite: 69]. Cells were then exposed to 500 µCi (1 Ci = 37 GBq) of [35S]Met/[35S]Cys (Amersham Pharmacia Biosciences) per well for 3 h, rinsed three times with warm PBS, and chased in complete medium containing 1% L-glutamine, 2 mM L-methionine, 2 mM L-cysteine, and 10% FCS for various times up to 8 h[cite: 70]. Cells were lysed in buffer containing 150 mM NaCl, 5 mM EDTA, 50 mM Tris (pH 7.6), 0.25% Nonidet P-40, 1 mM PMSF, and protease inhibitors[cite: 71]. Transfected proteins were immunoprecipitated by using anti-GFP conjugated to agarose (Vector Laboratories), and products were eluted with sample buffer and separated by SDS/PAGE[cite: 72]. After electrophoresis, the gel was fixed (isopropyl alcohol/water/acetic acid, 25:65:10), enhanced with Amplify (Amersham Pharmacia Biosciences) for 30 min, and dried for autoradiography on a Storm PhosphorImager[cite: 73]."
            },
            "Readout type": "Quantitative",
            "Readout description": [                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "N.D."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "The half-life of wild-type N-terminal GFP-tagged PINK1 was ≈2 h, whereas the L347P mutation had a half-life of 0.25 h[cite: 171]."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Similar estimates of stability were obtained in duplicate experiments[cite: 188]."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type N-terminal GFP-tagged PINK1[cite: 184]."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Immunofluorescence Staining",
            "Material used": {
                "Material Source": "Mammalian Cells",
                "Material Name": "COS-7 cells",
                "Description": "Cells were stained with MitoTracker (Molecular Probes) and transfected PINK1 as described in refs. 11 and 23 for DJ-1, except that primary antibodies were either anti-GFP or anti-myc (both at 1:200 dilution)[cite: 81, 82]. GFP-tagged PINK1 was observed directly in transfected cells without fixation[cite: 157]. For myc-tagged PINK1, after fixation, myc staining was revealed by using anti-myc monoclonal antibody (green in f and i) and compared with MitoTracker (red in g and h)[cite: 124]."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "G309D PINK1, however, appeared to be normally localized [cite: 174] and, like wild-type or kinase-dead proteins, was present in cytosolic inclusions in some cells[cite: 174]."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of function",
                    "Result Description": "Consistent with the lower steady-state levels of protein observed by using blotting, L347P PINK1 gave much lower levels of immunostaining, especially for the C-terminal constructs[cite: 173]."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Each image is representative of at least three experiments performed in duplicate for each construct[cite: 127]."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each image is representative of at least three experiments performed in duplicate for each construct[cite: 127]."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 was used for localization studies[cite: 176]."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Untransfected cells were shown as a control[cite: 122]. Kinase-dead PINK1 was used as a control[cite: 172]."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}